BPL Medical Technologies acquires Penlon

03 September 2015 | News | By BioSpectrum Bureau

BPL Medical Technologies acquires Penlon

Penlon will continue to be based and operated from the UK under the leadership of the existing management team

Penlon will continue to be based and operated from the UK under the leadership of the existing management team

BPL Medical Technologies ("BPL Medical"), has announced the acquisition of Penlon("Penlon"), a UK-based, leading global manufacturer of anaesthesia systems and vaporizers with worldwide distribution networks.

Penlon's product range complements BPL Medical's existing portfolio and will help in expanding its presence in the critical care segment. Penlon will continue to be based and operated from the UK under the leadership of the existing management team.

The company designs, engineers and manufactures anaesthesia systems, vaporizers and other complementary products. These products are sourced by hospitals, pharmaceutical companies and anaesthesia system manufacturers worldwide. Penlon has a reputation for exceptional product quality and prompt after sales support and services.

BPL Medical is one of the largest Indian medical devices companies with over 300 personnel and a large distributor network located across India. In August of 2013 Goldman Sachs invested in BPL Medical to fund the expansion of its medical devices business. This latest acquisition will increase BPL Medical's presence and distribution in other emerging and developed markets.

Mr Sunil Khurana, chief executive officer of BPL Medical said, "This acquisition will help us penetrate the large critical care segment in India with Penlon's world-renowned technology-driven anaesthesia machines and vaporizers. BPL Medical will leverage Penlon's R&D capabilities to develop many new products suitable for India and other emerging markets. Additionally, Penlon's global reach will help expand BPL Medical's international presence."

 

Mr Stephen Moon, Chief Executive Officer of Penlon, said, "This partnership secures a long-term investment which underpins our product strategy to develop world class anaesthesia machines, monitors and next-generation vaporizers over the coming years. We now plan to expand our product development capabilities across the business and will bring forward a number of key projects. We will also benefit from BPL Medical's strength in India which will provide substantial growth in the years to come."

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account